Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleSpecial Communications

The Law of Diminishing Returns in Clinical Medicine: How Much Risk Reduction is Enough?

James W. Mold, Robert M. Hamm and Laine H. McCarthy
The Journal of the American Board of Family Medicine May 2010, 23 (3) 371-375; DOI: https://doi.org/10.3122/jabfm.2010.03.090178
James W. Mold
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert M. Hamm
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laine H. McCarthy
MLIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. ↵
    Economy Professor. Law of diminishing returns. The Professor Network, 2009. Available at www.economyprofessor.com/economictheories/law-of-diminishing-returns.php. Accessed 14 April 2009.
  2. ↵
    Johnson HA. Diminishing returns on the road to diagnostic certainty. JAMA 1991; 265: 2229–31.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Sonnenberg A. Diminishing returns on sequential interventions of gastroenterology. Eur J Gastroenterol Hepatol 2008; 20: 465–8.
    OpenUrlPubMed
  4. ↵
    Luke B, Hediger ML, Scholl TO. Point of diminishing returns: when does gestational weight gain cease benefiting birthweight and begin adding to maternal obesity? J Matern Fetal Med 1996; 5: 166–73.
    OpenUrl
  5. ↵
    American Diabetes Association. Standards of medical care in diabetes—2008. Diabetes Care 2008; 31(Suppl 1): S12–S54.
    OpenUrlFREE Full Text
  6. ↵
    American Diabetes Association. Living with diabetes. Diabetes PHD. Available at http://www.diabetes.org/living-with-diabetes/complications/diabetes-phd/. Accessed 15 March 2010.
  7. ↵
    Eddy DM, Schlessinger L. Validation of the Archimedes diabetes model. Diabetes Care 2003; 26: 3102–10.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care 2003; 26: 3093–101.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008; 337: a1840.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Ogawa H, Nakayama M, Morimoto T, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes. JAMA 2008; 300: 2134–41.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events. Report no. APPIP02-0004. Washington, DC: Agency for Healthcare Research and Quality.
  12. ↵
    Kannel WB, Schatzkin A. Risk factor analysis. Prog Cardiovasc Dis 1983; 26: 309–32.
    OpenUrlWeb of Science
  13. ↵
    Gerstein HC, Pogue J, Mann JFE, et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 2005; 48: 1749–55.
    OpenUrlCrossRefPubMedWeb of Science
  14. Haffner SM. Is there a glycemic threshold?. Arch Intern Med 1997; 157: 1791.
    OpenUrlCrossRefPubMed
  15. Krolewski AS, Laffel LMB, Krolewski BA, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminaria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251–5.
    OpenUrlCrossRefPubMedWeb of Science
  16. Orchard TJ, Forrest KY-Z, Ellis D, Becker D. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus: the glycemic threshold revisited. Arch Intern Med 1997; 157: 1851–6.
    OpenUrlCrossRefPubMedWeb of Science
  17. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997; 127: 788–95.
    OpenUrlPubMedWeb of Science
  18. Warram JH, Manson JE, Krolewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1305–6.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Action to Control Cardiovascular Risk in Diabetes Study Group (ACCORD), Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Courtney DL. Medication reduction strategies. Compr Ther 1996; 22: 318–23.
    OpenUrlPubMed
  21. Stoehr GR, Lu S-Y, Lavery L, Vander Bilt J, Saxton JA, Chang C-C. Factors associated with adherence to medication regimens in older primary care patients: the Steel Valley Seniors Survey. Am J Geriatr Pharmacother 2008; 6: 255–63.
    OpenUrlCrossRefPubMed
  22. ↵
    Williams AF, Manias E, Walker R. Adherence to multiple, prescribed medications in diabetic kidney disease: a qualitative study of consumers’ and health professionals’ perspectives. Int J Nurs Stud 2008; 45: 1742–56.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    Boyd CM, Darer J, Boult C, Fried LP, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple-co-morbid diseases: implications for pay for performance. JAMA 2005; 294: 716–24.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    Mold JW. An alternative conceptualization of health and health care: its implications for geriatrics and gerontology. Educ Gerontol 1995; 21: 85–101.
    OpenUrlCrossRefWeb of Science
  25. ↵
    Mold JW, Blake GH, Becker LA. Goal-oriented medical care. Fam Med 1991; 23: 46–51.
    OpenUrlPubMed
  26. ↵
    Mold JW, Hamm R, Scheid D. Evidence-based medicine meets goal-directed health care. Fam Med 2003; 35: 360–4.
    OpenUrlPubMed
  27. ↵
    Lee TH. “Me-Too” products—friend or foe? N Engl J Med 2004; 350: 211–2.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    Zubialde JP, Mold JW. Relational value: bridging the worldview gap between patients and health systems. Fam Med 2001; 33: 393–8.
    OpenUrlPubMed
  29. ↵
    Jacobson TA. “The lower the better” in hypercholesterolemia therapy: a reliable clinical guideline? Ann Intern Med 2000; 133: 549–54.
    OpenUrlPubMedWeb of Science
  30. ↵
    Learmonth ID. Total hip replacement and the law of diminishing returns. J Bone Joint Surg 2006; 88-A: 1664–73.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Medicine: 23 (3)
The Journal of the American Board of Family Medicine
Vol. 23, Issue 3
May-June 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Law of Diminishing Returns in Clinical Medicine: How Much Risk Reduction is Enough?
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Law of Diminishing Returns in Clinical Medicine: How Much Risk Reduction is Enough?
James W. Mold, Robert M. Hamm, Laine H. McCarthy
The Journal of the American Board of Family Medicine May 2010, 23 (3) 371-375; DOI: 10.3122/jabfm.2010.03.090178

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Law of Diminishing Returns in Clinical Medicine: How Much Risk Reduction is Enough?
James W. Mold, Robert M. Hamm, Laine H. McCarthy
The Journal of the American Board of Family Medicine May 2010, 23 (3) 371-375; DOI: 10.3122/jabfm.2010.03.090178
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case
    • Risk Reduction
    • Prioritization
    • Conclusions
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • Guest Family Physician Commentaries
  • PubMed
  • Google Scholar

Cited By...

  • Goal-Oriented Prevention: How to Fit a Square Peg into a Round Hole
  • Goal-Oriented Prevention: How to Fit a Square Peg into a Round Hole
  • Failure of the Problem-Oriented Medical Paradigm and a Person-Centered Alternative
  • Incremental effects of antihypertensive drugs: instrumental variable analysis
  • A cardiovascular disease policy model: part 2--preparing for economic evaluation and to assess health inequalities
  • Encouraging Patient-Centered Care by Including Quality-of-Life Questions on Pre-Encounter Forms
  • The Changing Face of Chronic Illness Management in Primary Care: A Qualitative Study of Underlying Influences and Unintended Outcomes
  • The Complexity of Family Medicine Care
  • Policy and Financing in Family Medicine and the Medical Home
  • Guest Family Physician Commentaries
  • Google Scholar

More in this TOC Section

  • Integrating Community and Clinical Data to Assess Patient Risks with A Population Health Assessment Engine (PHATE)
  • Primary Care Is an Essential Ingredient to a Successful Population Health Improvement Strategy
  • Hepatitis C Update and Expanding the Role of Primary Care
Show more Special Communications

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire